Processing

Please wait...

Settings

Settings

Goto Application

1. WO2002004024 - COMPOSITION FOR THE TREATMENT OF DIABETES

Publication Number WO/2002/004024
Publication Date 17.01.2002
International Application No. PCT/CA2000/001152
International Filing Date 29.09.2000
IPC
A61K 33/24 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
A61K 38/28 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
28Insulins
A61K 45/06 2006.1
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/-A61K41/132
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
CPC
A61K 33/24
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
33Medicinal preparations containing inorganic active ingredients
24Heavy metals; Compounds thereof
A61K 38/28
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
17from animals; from humans
22Hormones
28Insulins
A61K 45/06
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
45Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
A61P 3/10
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
Applicants
  • RIEVELEY, Robert, B. [CA]/[CA]
Inventors
  • RIEVELEY, Robert, B.
Agents
  • OYEN, Gerald, O., S.
Priority Data
09/608,27230.06.2000US
Publication Language English (en)
Filing Language English (EN)
Designated States
Title
(EN) COMPOSITION FOR THE TREATMENT OF DIABETES
(FR) COMPOSITION DESTINEE AU TRAITEMENT DU DIABETE
Abstract
(EN) This invention is directed to a novel method and composition for the treatment of diabetes mellitus (Type I, Impaired Glucose Tolerance ['IGT'] and Type II). More specifically, this invention pertains to a novel method and composition for orally treating diabetes mellitus by a dministering to a person afflicted with diabetes mellitus one or more insulin sensitizer chemicals, which increase the cells ability to utilize glucose, together with one or more orally ingested medications for the treatment of diabetes mellitus. A method for the treatment of diabetes mellitus comprising administering to a person with diabetes mellitus a therapeutic amount of an insulin sensitizer with a therapeutic amount of an anti-diabetic agent.
(FR) L'invention concerne un nouveau procédé et une nouvelle composition destinés au traitement du diabète sucré (de type I, intolérance au glucose ['IGT'] et de type II). Cette invention concerne plus particulièrement un nouveau procédé et une nouvelle composition destinés au traitement oral du diabète sucré par administration d'un ou de plusieurs insulinosensibilisants chimiques à une personne atteinte de diabète sucré, insulinosensibilisants permettant d'accroître la capacité cellulaire à utiliser du glucose, et par administration d'un ou de plusieurs médicaments ingérés oralement pour le traitement du diabète sucré. L'invention concerne également un procédé destiné au traitement du diabète sucré par administration d'une quantité thérapeutique d'un insulinosensibilisant avec une quantité thérapeutique d'un agent anti-diabètique à une personne atteinte de diabète sucré.
Related patent documents
Latest bibliographic data on file with the International Bureau